Search

Author/Creator Ross, Merrick

11. Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials. Issue 1 (19th September 2017)

Authors:
Kaufman, Howard L.; Andtbacka, Robert H. I.; Collichio, Frances A.; Wolf, Michael; Zhao, Zhongyun; Shilkrut, Mark; Puzanov, Igor; Ross, Merrick
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 5:Issue 1(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. (November 2018)

Authors:
Amaria, Rodabe; Reddy, Sangeetha; Tawbi, Hussein; Davies, Michael; Ross, Merrick; Glitza, Isabella; Cormier, Janice; Lewis, Carol; Hwu, Wen-Jen; Hanna, Ehab; Diab, Adi; Wong, Michael; Royal, Richard; Gross, Neil; Weber, Randal; Lai, Stephen; Ehlers, Richard; Blando, Jorge; Milton, Denái; Woodman,...
Journal:
Nature medicine
Issue:
Volume 24:Number 11(2018)
Page Start:
1649
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. (December 2018)

Authors:
Amaria, Rodabe; Reddy, Sangeetha; Tawbi, Hussein; Davies, Michael; Ross, Merrick; Glitza, Isabella; Cormier, Janice; Lewis, Carol; Hwu, Wen-Jen; Hanna, Ehab; Diab, Adi; Wong, Michael; Royal, Richard; Gross, Neil; Weber, Randal; Lai, Stephen; Ehlers, Richard; Blando, Jorge; Milton, Denái; Woodman,...
Journal:
Nature medicine
Issue:
Volume 24:Number 12(2018)
Page Start:
1942
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗